It is a mutation in a gene that causes the eye disease glaucoma, according to a joint study conducted by Swedish researchers, Americans and Tunisians. The results were published recently in the journal Nature Genetics.Scientists have studied the Tunisian families who were affected with both glaucoma and microphthalmia, eyeballs fell, and in this work, have successfully identified the gene that is mutated and causes of the disease.S. research team participating in this collaboration, a modified version of the gene identified in a mutagenesis screen in mice selected for glaucoma.
. Accessed April 29, 2008. Based on its efficacy and tolerability, LUMIGAN 0.Glaucoma, a group of eye diseases characterized by damage to the optic nerve, is a leading cause of preventable blindness in the US2 An estimated 3 million Americans have glaucoma but only half of the people know that ‘it is . CSPI found that a departure from its analysis, and found that seven states had record relationships, better yet, including Maine, Kansas, Wyoming, Vermont, Alaska, Hawaii and North Dakota.01 percent provides physicians with a drug effective, safe and well tolerated for IOP in glaucoma patients, who are either starting treatment or change their treatment regimen, said Scott Whitcup, MD , President of Allergan Vice President, Research and Development, Chief Scientific Officer..
Previously it was believed that glaucoma is caused by high pressure in the eye. But now Peter S derkvist and Mounira hman-AIFA at the Faculty of Health Sciences, Link ping University in Sweden, in collaboration with the Tunisian and American researchers were able to identify the gene PRSS56 pathogen, which is a serine protease.
However, it remains unclear which protein is the substrate of PRSS56.